Intel CEO Lip-Bu Tan Buys $10 Million in Stock as Shares Rally 300%
Key Takeaways
- •Intel CEO Lip-Bu Tan invested $10 million of personal funds in 105,263 company shares at $95 each, increasing his total holding to approximately 1.3 million shares.
- •The insider purchase coincided with Intel's upsized secondary equity offering, which priced at $95 per share and raised an estimated $20 billion, potentially reaching $23 billion if additional options are exercised.
- •Intel shares have surged between 270% and 315% over the trailing twelve months, with year-to-date gains surpassing 149%.
- •Since becoming CEO in March 2025 after Pat Gelsinger's ouster, Tan has combined aggressive cost-cutting with a refocus on the 18A manufacturing node, now in mass production.
- •Intel's Q2 2026 revenue grew 25% year-on-year to $16.1 billion and beat EPS consensus, while the US government converted CHIPS Act funding into an equity stake in the company.

Intel CEO Lip-Bu Tan has put $10 million of his own money into his company's stock — an insider purchase that lands just as Intel shares have roughly tripled over the past year.
According to SEC filings — the disclosures that insiders at US-listed companies are required to file when they buy or sell stock — Tan acquired 105,263 shares of Intel common stock at $95 per share around August 11, 2026. The transaction lifts his total stake to approximately 1.3 million shares, held primarily through a family trust.
Backing a $20 Billion Capital Raise
The purchase was not made in isolation. It coincided with Intel's upsized secondary equity offering — a sale of newly issued shares to investors — which priced shares at $95 and raised an estimated $20 billion, a figure that could climb to $23 billion if additional options are exercised. Proceeds are earmarked for Intel's expansion in AI-related chip manufacturing.
Intel's stock has surged between 270% and 315% over the trailing 12 months through late August 2026. Year-to-date gains alone exceed 149%.
The Tan Turnaround
Lip-Bu Tan assumed the chief executive role on March 18, 2025, stepping in after the board ousted Pat Gelsinger amid a stretch of corporate turmoil marked by steep stock declines and significant layoffs. Tan, who previously served on Intel's board and led venture capital firm Walden International, paired aggressive cost-cutting with a strategic refocus on advanced chip manufacturing processes — most notably the 18A node, the leading edge of Intel's process technology, which is now in mass production.
Intel's Q2 2026 results showed a 25% year-on-year revenue increase to $16.1 billion, beating earnings-per-share consensus estimates. Meanwhile, the US government converted CHIPS Act funding into an equity stake in Intel — a step rooted in the CHIPS and Science Act of 2022, the federal law designed to bolster domestic semiconductor manufacturing — providing capital while signaling Washington's strategic interest in keeping advanced chip manufacturing on American soil.
What the Insider Buy Signals
A $10 million purchase by an executive already holding more than a million shares suggests Tan sees meaningful upside even after a 300% rally. There is a reasonable counterargument, however: buying shares during one's own company's equity offering can be viewed partly as a show of solidarity with new investors, and CEOs at firms conducting large capital raises often participate for optics as much as conviction.
Intel's positioning is distinct from that of companies like Nvidia, which dominate on the design and GPU side. Intel is wagering that being the manufacturer — the company actually fabricating advanced chips for itself and, potentially, for others — will prove equally valuable as AI workloads proliferate. That is the same contract-manufacturing, or foundry, model on which rival TSMC built its business.
The risk side of the ledger is not empty. A $20 billion equity raise dilutes existing shareholders, and competitors in the foundry space, particularly TSMC, are not standing still. Still, a company that was trading below $20 in 2024 now commands $95 per share and has just raised $20 billion from institutional investors willing to pay that price. Whether the offering's additional options are exercised — lifting proceeds toward $23 billion — and how the new capital is deployed into AI-chip manufacturing capacity are the immediate markers to watch next.